IMMX.O (IMMX.O) News
Follow IMMX.O (IMMX.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Immix Biopharma prices 11,363,637 share offering at $11.00 raising $125 million gross
Immix Biopharma priced an underwritten offering of 11,363,637 common shares at $11.00 each, for gross proceeds of about $125 million before underwriting discounts and expenses. Closing is expected on or about Sept. 30, 2
EQUITY | Sep 29, 2026, 11:11 AM UTC
M
Immix Biopharma reports 2 interim NEXICART-2 data: 89% complete response in AL amyloidosis
Immix Biopharma said NXC-201 interim results in relapsed or refractory AL amyloidosis showed an 89% complete response rate across patients, with no relapses reported so far among those with deep responses and no neurotox
EARNINGS | Sep 29, 2026, 11:03 AM UTC